Long-term cholesterol medicines after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a recent heart attack called STEMI or NSTEMI, confirmed by ECG and blood tests (troponin I and CPK-MB) plus a heart scan of the arteries
- Your heart artery scan shows an artery connected to the heart attack
- You do not have major narrowing in multiple coronary arteries (over 30%)
- You have not had another heart attack again recently
- You can take cholesterol medicines: you are not intolerant to statins or ezetimibe
- You do not have certain health problems (for example: advanced kidney disease, uncontrolled blood pressure, severe anemia, or major rhythm/heart conduction problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial tests giving strong cholesterol-lowering medicine within 24 hours after a heart attack to see if it helps recovery. It is for people who have had a recent heart attack and are getting a stent placed.
This trial tests whether adding two extra medicines to a common cholesterol-lowering statin lowers LDL ('bad') cholesterol more effectively in people recently hospitalized for a heart attack or unstable chest pain.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
This study tests whether a stronger-than-usual cholesterol-lowering treatment right after a heart attack (STEMI or NSTEMI) can improve outcomes. It may help protect the heart by lowering harmful cholesterol quickly.
Hear when a new Arterial Stiffness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.